Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Mesenchymal Precursor Cells as Adjunctive Therapy in Recipients of Contemporary LVADs: A Multi-Center Prospective Randomized Placebo-Controlled Double-Blinded Clinical Trial. Circulation Ascheim , D. D., Geljins, A. C., Goldstein, D., Moye, L. A., Smedira, N., Lee, S., Klodell, C. T., Szady, A., Parides, M. K., Jefferies, N., Skerret, D., Taylor, D. A., Rame, J. E., Milano, C., Rodgers, J. G., Lynch, J., Dewey, T., Eichhorn, E., Sun, B., Feldman, D., Simiari, R., O'Gara, P. T., Taddei-Peters, W., Miller, M. A., Woo, Y. J., et al 2014; (in press)